The current research planned to unravel RMRP-mediated proliferation, apoptosis, and glycolysis processes in ESCC and further determined its interplay with miR-580-3p and the downstream target ATP13A3, hoping to provide more evidence for molecule-based targeted therapies for ESCC. Here, ATP13A3 is linked to esophageal squamous cell carcinoma.